5 Februar 2016

AVA Biochem adds FDCA to its product portfolio

New process for cost-efficient oxidation of 5-HMF to FDCA

AVA Biochem, world leader in 5-HMF production, is expanding its product portfolio to include platform chemical FDCA (2,5-Furandicarboxylic acid). In addition to 5-HMF, the Swiss company will now deliver high-quality FDCA to customers and partners engaged in research and development of new products.

Furan derivatives produced from renewable carbohydrates are some of the most important next-generation platform chemicals. In 2004, the US Department of Energy classed FDCA as one of the 12 most important platform chemicals in the world.

AVA Biochem’s 5-HMF production is based on hydrothermal processing technology (HPT) and is an excellent, cost-efficient basis for the oxidation of 5-HMF to FDCA. Significant cost advantages can be realised on an industrial scale, paving the way for competitively priced bio-based packaging solutions in the future.

FDCA produced from 5-HMF allows for the production of bio-based PEF (polyethylene furanoate) and other materials. Thanks to a variety of sought after product advantages, these materials will help bio-based plastics to massively grow its share in the billion-dollar packaging market.

“Expanding the product portfolio to include FDCA is another important milestone for AVA Biochem. This will significantly accelerate market development of 100% bio-based plastic packaging based on PEF, a renewable replacement material for PET”, explains Thomas Kläusli, Chief Marketing Officer of the Swiss biochemical company.

Source: AVA Biochem, press release, 2016-02-01.

Supplier

Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email